Mochida Pharmaceutical Co.,Ltd. [4534.T]
TOKYO, May 15 (Pulse News Wire) – Mochida Pharmaceutical Co., Ltd. (4534.T) reported consolidated results for fiscal year 2026 ending March.
Revenue was ¥120 billion (+11.2% YoY). operating profit was ¥10,147 million (+24.9%). net profit attributable to shareholders was ¥7,903 million (+39.0%).
Total assets stood at ¥180 billion with an equity ratio of 76.8%. The company declared an annual dividend of ¥40 per share. The full-year forecast for the current fiscal year is revenue of ¥130 billion (+7.7%).
Financial results — FY2026/3 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥116,951M | +11.2% |
| Operating profit | ¥10,147M | +24.9% |
| Net profit | ¥7,903M | +39.0% |
Next period forecast
Revenue
¥126,000M
+7.7%Op. profit
¥10,500M
+3.5%Net profit
¥10,000M
+26.5%Source: TDNet filing · Figures in millions of yen
🟢 Confidence: High AI-translated content.